Skip to main content

Site notifications

AusPAR: Apretude

Device/Product Name
Apretude
Active ingredients
Cabotegravir (as sodium (tablet), and as free acid (suspension for injection))
AusPAR Date
Published
Submission Number
PM-2021-04853-1-2
Submission Type
Extension of indications
Decision
Approved

Help us improve the Therapeutic Goods Administration site